The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

While Food and Drug Administration inspectors who make sure food and drugs meet quality standards were spared in recent cuts, ...

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...